It's not too late - you can still register to H321 UK and US Market Webinars
Accelerate your UK or US market entry with support from Health 3-2-1

Does your SME offer smart solutions in the life science area?  
Do you want to generate sales in the UK and US markets?
Do you need business collaborations and customized support to make it happen?

As part of the Health3-2-1 project, we invite you to UK and US market entry webinars, where we will explore an overview of the markets, business culture and introduction to soft-landing schemee. The webinars are organized by the partners Tallinn Science Park Tehnopol (EE), Turku Science Park (FI) and Swecare (SE).

We think you have 
  • Interesting and creative ideas
  • An interest in and readiness to commit to the selected markets 
  • Innovation as a driver 
  • State-of-the-art solutions
  • Unique offers 

We think you want 
  • Bigger muscles 
  • More experience on your selected market
  • Access to new markets
  • Access to trusted networks
  • A network with like minded companies in Estonia and Finland 
  • Investmens, and paying costumers

Are YOU the one we´re looking for? Join our webinars and find out - and then apply to the the Health 321 program. The value offered to selected companies is estimated at 20,000 EUR, and the program will run until end of 2026.

UK markets: 17/10 at 12:00 CET/13:00 EET

The session was really great and offered a lot of valuable insights for life sciences SMEs, including tips and tricks from a company that is successfully navigating the UK market.

Link to recording

UK markets: 29/10 at 13:00 CET/14:00 EET

The webinar will look into business culture and ptiching as well as resources available in the UK to support life science companies entering the market, and specifically London.

More info and registration

US markets: 24/10 at 15:00 CET/16:00 EET

The session will give an overview of the US healthcare and life sciences market, and specific information from representatives from the states of Massachusetts, Virginia and Pennsylvania (TBC).

US markets: 31/10 at 15:00 CET/16:00 EET

You will learn more about business culture in the US, as well as more specific information on soft-landing schemes for life science companies in the three states. 

About Health 3-2-1
Health 3-2-1 is an EU Interreg-funded project led by Tallinn Tehnopol (EE), Business Turku (FI), and Swecare (SE). The project aims to support small and medium-sized enterprises in the life sciences sector as they expand into export markets in the UK (London) and the US (Massachusetts or the East Coast around Greater Washington area).  

Selected companies will receive a comprehensive support package valued up to €20,000, which includes tailored mentoring, thematic seminars and up to two business missions to the target markets. A limited number of companies will be selected to participate and receive support in reaching active sales. 

The program receives support from the European Union through the Central Baltic programme.